Latest Cancer News

More Risk than Benefit with TSH Suppression in Thyroid Cancer without High Risk of Recurrence (05-21-2015)
For patients undergoing treatment for thyroid cancer who aren’t at high risk of recurrence, therapy to suppress thyrotropin (TSH) may be ineffective as well as risky. These findings were published in... Continue Reading

Xilonix™ Promising as Treatment for Non–Small Cell Lung Cancer (05-20-2015)
The new targeted agent Xilonix™ appears effective in the treatment a non–small cell lung cancer (NSCLC). The biotechnology company XBoitech Inc recently announced clinical trial findings for the drug.[i],[ii] Xilonix... Continue Reading

Target Therapy Sutent® Promising in Advanced Thyroid Cancer (05-19-2015)
The targeted therapy Sutent® (sunitinib) appears effective in the treatment of patients with advanced differentiated thyroid cancers. The Endocrine Society announced these Phase II trial findings in a... Continue Reading

More Cancer News

Events

Tower Oncology’s Cancer Support Network Brings New Services to West Side
Organizations partner to offer full range of cancer support and education to meet a growing need. Read more…


Tower Hematology Oncology Medical Group Named Fight Back Chair For American Cancer Society’s Relay for Life Event in Beverly Hills
Cancer treatment center seeks volunteers, donations for April 30 cancer support fundraiser
Read more…

Tower News

Tower Hematology Oncology Medical Group has been awarded a three-year term of accreditation in computed tomography (CT) and positron emission tomography (PET) as the result of a recent review by the American College of Radiology (ACR). CT scanning — sometimes called CAT scanning — is a noninvasive medical test that helps physicians diagnose and tailor treatments for various medical conditions. Learn more…

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map